Serenity Pharmaceuticals LLC

Above the Fold, LLC

Allergan, Inc.

Samuel Herschkowitz

Seymour H Fein

Deborah B Adler

Gareth Brown

Eric Freitag

Pepin S Gelardi

Matthew Chin

Theodore R Ullrich

Stephen Kaes

Robert R Pascazio

Abby Herzig

Erin Woo

Khoi Uong

Mike Klodginski

Ritik Dholakia

Troy Yoshimoto

Seymour Fein

Joshua Kornberg

Linda Cheng

Maria Cheng

Pepin Gelardi

Deborah Adler

The present disclosure relates to integrated systems, methods and apparatuses for assisting individuals in managing acute life-threatening conditions. A system in accordance with the current disclosure may comprise an electronic circuit configured to be attached to a container of a medication and one or more devices in communication with the electronic circuit in a private network. In an aspect, the one or more devices may work in concert to determine the safety level of an individual based on predetermined usage settings. In some aspects, the system may be configured to determine whether a medication would expire before its manufactured expiry date. In another aspect, the system may assist an individual in locating a medication. In a further aspect, the system may determine whether an individual is having an anaphylactic reaction. In some aspects, the system may detect a known allergen and alert the individual.

Systems for tracking medications

The invention provides methods and compositions for use of desmopressin in combination with a beta-3-adrenergic receptor agonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.

Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist

The invention provides methods and compositions for use of desmopressin in combination with an alpha-adrenergic receptor antagonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.

Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist

The invention provides methods and compositions for use of desmopressin in combination with a 5-alpha reductase inhibitor. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.

Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor

Disclosed are devices for urine voiding postponement, and methods for treating conditions such as central diabetes insipidus, enuresis, nocturia, urinary frequency or incontinence. The devices deliver a desmopressin flux through the skin of a patient in a low dose amount just necessary to achieve a desired anti-diuretic effect without undesirable side effects such as hyponatremia. The devices are designed to permit a state of normal urinary production to return quickly after the desmopressin flux is terminated.

Methods and devices for desmopressin drug delivery

Growing community of inventors

Brooklyn, NY, United States of America

Samuel Herschkowitz